Sage Journals: Discover world-class research

Abstract

There is a lack of clear evidence and guidelines on how to reverse anticoagulation prior to emergency and elective urological procedures. Our aim was to produce local hospital guidelines based on current evidence to simplify the perioperative process of stopping traditional and novel oral anticoagulants and antiplatelet therapy.

Keywords

Anticoagulation antiplatelet novel oral anticoagulant

Get full access to this article

View all access options for this article.

References

Ellis

John Camm

Datta

SN.

Novel anticoagulants and antiplatelet agents; a guide for the urologist. BJU Int 2015; 116: 687–696.

Meyer

Gillatt

Lush

et al . Managing the warfarinized urological patient. BJU Int 2003; 92: 351–354.

Green

Mendes

Van der Valk

et al . Novel anticoagulants – an update on the latest developments and management for clinicians treating patients on these drugs. J Oral Pathol Med 2016; 45: 551–556.

Wolberg

Rosendaal

Weitz

et al . Venous thrombosis. Nat Rev Dis Primers 2015; 1: 15006.

Oprea

Noto

Halaszynski

TM.

Risk stratification, perioperative and periprocedural management of the patient receiving anticoagulant therapy. J Clin Anesth 2016; 34: 586–599.

Levy

Faraoni

Spring

et al . Managing new oral anticoagulants in the perioperative and intensive care unit setting. Anesthesiology 2013; 118: 1466–1474.

Culkin

Exaire

Green

et al . Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paper. J Urol 2014; 192: 1026–1034.

Mukerji

Munasinghe

Raza

A survey of the peri-operative management of urological patients on clopidogrel. Ann R Coll Surg Engl 2009; 91: 313–320.

Kaul

Sorour

Wilson

. Bridging anticoagulation: The peri-procedural management of patients on oral anticoagulants, http://www.dbh.nhs.uk/Library/Pharmacy_Medicines_Management/Formulary/Formulary_S2/BridgingAnticoagulationGuideline_May2014.pdf (accessed December 2016).

10.

Heidbuchel

Verhamme

Alings

et al . Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 2015; 17: 1467–1507.

11.

Baron

Kamath

McBane

RD.

Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med 2013; 368: 2113–2124.

12.

National Institute for Health and Care Excellence. Reversal of the anticoagulant effect of dabigatran: Idarucizumab, https://www.nice.org.uk/advice/esnm73/chapter/Key-points-from-the-evidence (accessed May 2017).

13.

Lip

GYH

Douketis

. Perioperative management of patients receiving anticoagulants, http://www.uptodate.com/contents/perioperative-management-of-patients-receiving-anticoagulants (accessed May 2016).

14.

Bertrand

ME.

When and how to discontinue antiplatelet therapy. Eur Heart J Suppl 2008; 10 (Suppl A): A35–A41.

15.

Sié

Samama

Godier

et al . Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis. Arch Cardiovasc Dis 2011; 104: 669–676.

16.

van Veen

Makris

. Management of peri-operative anti-thrombotic therapy. Anaesthesia 2015; 70 (Suppl 1): 58–67,e21–e23.

Guideline for stopping anticoagulants prior to urological procedures

Abstract

Keywords

Get full access to this article

References